Skip to main content

Major Depressive Disorder News (Page 22)

Related terms: Clinical Depression, Unipolar Disorder, MDD

FDA Approves Rexulti (brexpiprazole) for Schizophrenia and Adjunctive Treatment for Major Depressive Disorder

Tokyo, Japan and Valby, Denmark – July 11, 2015 –Otsuka Pharmaceutical Co., Ltd. (Otsuka) and H. Lundbeck A/S (Lundbeck) announced today that the U.S. Food and Drug Administration (FDA) approved Rex...

Actavis Receives FDA Approval for Viibryd (vilazodone HCl) 20mg Once Daily as a Therapeutic Dose

DUBLIN, March 16, 2015 /PRNewswire/ – Actavis plc (NYSE: ACT) today announced the U.S. Food and Drug Administration (FDA) has approved a lower therapeutic dose of Viibryd (vilazodone HCl) (20mg) to...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Depression

Related drug support groups

Lexapro, Zoloft, sertraline, Wellbutrin, Cymbalta, trazodone, Prozac, Effexor, escitalopram, view more... bupropion, mirtazapine, Abilify, venlafaxine, fluoxetine, Paxil, Effexor XR, Pristiq, Wellbutrin XL, Viibryd, duloxetine, Trintellix, quetiapine, Remeron, Wellbutrin SR, Vraylar, paroxetine, olanzapine, Zyprexa, vortioxetine, aripiprazole, Rexulti, Seroquel XR, doxepin, Auvelity, desvenlafaxine